New Drug Combination Shows Promise As Prostate Cancer Treatm

A new drug combination for men with advanced prostate cancer has shown sustained increase in survival rates.The results from the clinical trial of ENZAMET, co-chaired by Professor Christopher Sweeney, Director of the South Australian immunoGENomics C

Related Keywords

Australia , University Of Adelaide , South Australia , New Zealand , Australian , Christopher Sweeney , Genomics Cancer Institute Sai , Central Adelaide Local Health Network , University Of Adelaide Faculty Health , Prostate Cancer Trials Group , Professor Christopher Sweeney , South Australian , Cancer Institute , Lancet Oncology , New Zealand Urogenital , Medical Sciences ,